fda English news | fda, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

The former head of the US Food and Drug Administration (FDA) on Monday said that circumstantial evidence of COVID-19 originating in a lab in China's Wuhan continues to grow as researchers are yet to prove that the virus jumped from an animal to humans, The Hill reported.Former FDA commissioner Scott Gottlieb told US media that circumstantial evidence to suggest the lab leak theory is increasing."I think the challenge right now is that the side of the ledger that supports the thesis that this [COVID-19] came from a zoonotic source, from an animal source, hasn't budged and the side of the ledger that suggests this could have come out of a lab has been continuing to grow," he said.Gottlieb also said the intermediate host of the virus has not been found, which was in contrast with MERS and SARS, where the intermediate host was located.He noted that it is unlikely the world will ever know for sure whether COVID-19 escaped from the lab unless there's a whistleblower or regime change in China, The Hill reported.Three researchers from China's Wuhan Institute of Virology sought hospital care after they fell ill in November 2019, a month before Beijing reported the first patient with COVID-like symptoms, the Wall Street Journal reported earlier."The US government has reason to believe that several researchers inside the WIV became sick in autumn 2019, before the first identified case of the outbreak, with symptoms consistent with both COVID-19 and common seasonal illnesses," the report read, fueling debate of the lab leak theory.The revelations come amid growing calls for a fuller probe on whether the COVID-19 virus may have escaped from the Chinese laboratory. It also comes on the eve of a meeting of the World Health Organization's (WHO) decision-making body, which is expected to discuss the next phase of investigation into the origin of COVID-19.Earlier this year, the WHO report determined that the possibility the virus came from a lab was "extremely unlikely," noting there was "no record" any lab had closely related viruses. The probe was criticised by the US, UK, and other governments over its limited access to "complete, original data and samples."The organization was also accused of being overly deferential to China throughout the course of the study, which was co-authored by 17 Chinese scientists -- several of them from state-run institutions.China refused to give raw data on early COVID-19 cases to the WHO-led team probing the origins of the pandemic. Beijing has been accused of delaying access to international investigators for months after the initial outbreak, virtually guaranteeing that the lab had been deep-cleaned before any forensic analysis could be done.Recently, Anthony Fauci, a top adviser to US President Joe Biden on the coronavirus pandemic said he's "not convinced" the deadly virus developed naturally and has called for further investigations into where it emerged."No actually. I am not convinced about that. I think we should continue to investigate what went on in China until we continue to find out to the best of our ability what happened," Fauci, the director of the National Institute of Allergies and Infectious Diseases said in a Poynter event.The controversy about COVID-19 origins has resurfaced after the Weekend Australian newspaper revealed that Chinese scientists were thinking about bioweapons, visualising a World War-III scenario.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

FdaFOLLOW

Fda, Latest News

Washington, June 8 The US Food and Drug Administration (FDA) approved a new drug, Aduhelm (aducanumab), for the ... ...

Aurangabad, June 2: “Covid has not over yet. We need to take care for at least five to six ... ...

New Delhi, June 2 Globally available Covid 19 vaccines can now be launched in India without the requirement ... ...

The Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other international regulatory bodies - a big move likely to clear the way for foreign vaccines like Pfizer and Moderna fo ...

Amid mounting concerns regarding a renewed probe of the origins of COVID-19 in China, former US Food and Drug Administration (FDA) Commissioner Scott Gottlieb said that accidental lab leaks 'happen all the time' and there have been six last known out ...

Aurangabad, May 25: The Aurangabad Bench of Bombay High Court comprising Justice Ravindra Ghuge and Justice B U Debadwar ... ...

Moderna on Tuesday announced that various studies have shown its COVID-19 vaccine was 100 per cent effective at preventing infection in adolescents aged 12 to 17 and it planned on submitting the findings to global regulators in days. ...

The former head of the US Food and Drug Administration (FDA) on Monday said that circumstantial evidence of COVID-19 originating in a lab in China's Wuhan continues to grow as researchers are yet to prove that the virus jumped from an animal to human ...